Abstract
Background:
We report the outcome of 67 patients after endovascular treatment of chronic Cerebrospinal venous insufficiency in patients with multiple sclerosis.
Material and methods:
For evaluating outcome, patients were divided into three groups with respective outcome after three, six and twelve months. Assessment of outcome was done by a disease-specific quality-of-life score that reflects the physical health (physical health composite, PHC) and mental health (mental health composite, MHC) by a score.
Results
Improvement in PHC was significant (P < 0.05) in the three- and six-month groups. Improvement in MHC was only significant (P < 0.05) in the three-month group.
Conclusion:
In conclusion, we can state that the result of endovascular treatment seems to decay although the baseline is still higher than preoperative. To confirm this finding, this study needs to be reproduced in a larger patient population.
Get full access to this article
View all access options for this article.